Sheng'an Zhou

Title: Sheng’an Zhou and Ophthalmic Pharmaceutical Innovation.

Introduction

Sheng’an Zhou is an inventor based in Guangzhou, China. His patent work includes a pharmaceutical composition intended for the prevention or treatment of cataracts.

Latest Patents

Zhou is associated with 1 patent, titled “Pharmaceutical Composition, Preparation Method Therefor and Application Thereof.” The invention describes a composition containing a compound represented by Formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator.

The composition is proposed for use in preparing medicines to prevent or treat cataracts. According to the patent description, it offers stability under light exposure and high temperatures and can be stored at room temperature. Its pH and osmotic pressure are designed to be close to those of the intraocular environment, while its particle-size distribution is uniform to support patient comfort.

Career Highlights

Zhou’s listed company affiliations include Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. and Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. His work reflects a focus on ophthalmic pharmaceutical development and formulations for cataract care.

Collaborations

His listed coworkers include Yandong Wang and Yingxue Su, who are associated with his professional and patent-related work.

Conclusion

Sheng’an Zhou’s patent centers on an ophthalmic pharmaceutical composition designed for stability, convenient storage, and patient comfort in potential cataract treatment.